Thus, our model predicts that administering EGFR-targeted drugs soon after tumor removal surgery can instead stimulate cancer cells to proliferate and to form new colonies in cooperation with internal molecules of EGF, which level may be increased following surgery. The gene discussed is EGF; the disease is neoplasm.